Filing Details

Accession Number:
0001140361-16-064140
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-09 20:47:28
Reporting Period:
2016-05-05
Filing Date:
2016-05-09
Accepted Time:
2016-05-09 20:47:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221590 Jacques Jean Bienaime C/O Biomarin Pharmaceutical Inc.
770 Lindaro St.
San Rafael CA 94901
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-05 10,000 $12.99 10,000 No 4 M Indirect Shares held in irrevocable trust for Guillaume Bienaime
Common Stock Disposition 2016-05-05 10,000 $80.15 0 No 4 S Indirect Shares held in irrevocable trust for Guillaume Bienaime
Common Stock Acquisiton 2016-05-05 10,000 $12.99 10,000 No 4 M Indirect Shares held in irrevocable trust for Pierre Bienaime
Common Stock Disposition 2016-05-05 10,000 $80.15 0 No 4 S Indirect Shares held in irrevocable trust for Pierre Bienaime
Common Stock Acquisiton 2016-05-05 10,000 $12.99 10,000 No 4 M Indirect Shares held in irrevocable trust for Paul Bienaime
Common Stock Disposition 2016-05-05 10,000 $80.15 0 No 4 M Indirect Shares held in irrevocable trust for Paul Bienaime
Common Stock Acquisiton 2016-05-05 10,000 $12.99 10,000 No 4 M Indirect Shares held in irrevocable trust for Marc Bienaime
Common Stock Disposition 2016-05-05 10,000 $80.15 0 No 4 S Indirect Shares held in irrevocable trust for Marc Bienaime
Common Stock Acquisiton 2016-05-05 20,000 $12.99 20,000 No 4 M Indirect Shares held in irrevocable trust for Aurelie Mitsuki Bienaime & Anais Kimiko Bienaime
Common Stock Disposition 2016-05-05 20,000 $80.15 0 No 4 S Indirect Shares held in irrevocable trust for Aurelie Mitsuki Bienaime & Anais Kimiko Bienaime
Common Stock Disposition 2016-05-06 5,479 $80.80 390,156 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect Shares held in irrevocable trust for Guillaume Bienaime
No 4 S Indirect Shares held in irrevocable trust for Guillaume Bienaime
No 4 M Indirect Shares held in irrevocable trust for Pierre Bienaime
No 4 S Indirect Shares held in irrevocable trust for Pierre Bienaime
No 4 M Indirect Shares held in irrevocable trust for Paul Bienaime
No 4 M Indirect Shares held in irrevocable trust for Paul Bienaime
No 4 M Indirect Shares held in irrevocable trust for Marc Bienaime
No 4 S Indirect Shares held in irrevocable trust for Marc Bienaime
No 4 M Indirect Shares held in irrevocable trust for Aurelie Mitsuki Bienaime & Anais Kimiko Bienaime
No 4 S Indirect Shares held in irrevocable trust for Aurelie Mitsuki Bienaime & Anais Kimiko Bienaime
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Common Stock Disposition 2016-05-05 10,000 $0.00 10,000 $12.99
Common Stock Stock Option (right to buy) Common Stock Disposition 2016-05-05 10,000 $0.00 10,000 $12.99
Common Stock Stock Option (right to buy) Common Stock Disposition 2016-05-05 10,000 $0.00 10,000 $12.99
Common Stock Stock Option (right to buy) Common Stock Disposition 2016-05-05 10,000 $0.00 10,000 $12.99
Common Stock Stock Option (right to buy) Common Stock Disposition 2016-05-05 20,000 $0.00 20,000 $12.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2006-11-11 2016-05-10 No 4 M Indirect
0 2006-11-11 2016-05-10 No 4 M Indirect
0 2006-11-11 2016-05-10 No 4 M Indirect
20,000 2006-11-11 2016-05-10 No 4 M Indirect
0 2006-11-11 2016-05-10 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 25,758 Indirect Shares held by Bienaime Family Trust
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 trading plan executed on August 17, 2015.
  2. The reporting person's spouse is the trustee of each child's trust.
  3. The price in column 4 is a weighted average price. The price actually received ranged from $79.46 to $82.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. Reflects the numbers of stock options outstanding after the transaction from this specific stock option grant.